The Company believes that this mechanism of action will be applicable for most types of solid tumors.
the SP is churning and chugging along and the "mechanism" will not be stopped... We are waiting for the Big News ....Big Money would rather wait for the results shown in/with a price increase and supporting patient runway to get underway... so the few of us accumulating early will have earned the biggest rewards...
Some of you may be questioning, like I was, how 600 different expressed antigens could possibly lead to 800 then 1200 different types of t-cell clones.
I asked that of ChatGPT (a poorman’s substitute for Dr.Prins or Dr.Bosch).
Here is what it said.
The diversity in T cell clones arises from their ability to recognize different epitopes of the expressed antigens. Even though there are 600 different peptides (tumor targets) presented by dendritic cells, each (different) T cell clone focuses on a particular and distinct target (epitope) within those peptides. So, multiple T cell clones can recognize different parts of the same expressed antigens, leading to the expansion of a diverse pool of T cells. 🔑